Acura Pharmaceuticals Stock Gross Profit
| ACURDelisted Stock | USD 0.05 0.00 0.00% |
Acura Pharmaceuticals fundamentals help investors to digest information that contributes to Acura Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Acura OTC Stock. The fundamental analysis module provides a way to measure Acura Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Acura Pharmaceuticals otc stock.
Acura |
Acura Pharmaceuticals OTC Stock Gross Profit Analysis
Acura Pharmaceuticals' Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Current Acura Pharmaceuticals Gross Profit | 1.79 M |
Most of Acura Pharmaceuticals' fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Acura Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
CompetitionAccording to the company disclosure, Acura Pharmaceuticals reported 1.79 M of gross profit. This is 99.92% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The gross profit for all United States stocks is 99.99% higher than that of the company.
Acura Gross Profit Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Acura Pharmaceuticals' direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Acura Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Acura Pharmaceuticals by comparing valuation metrics of similar companies.Acura Pharmaceuticals is currently under evaluation in gross profit category among related companies.
Acura Fundamentals
| Return On Asset | -0.38 | ||||
| Profit Margin | (0.51) % | ||||
| Operating Margin | (0.49) % | ||||
| Current Valuation | 3.49 M | ||||
| Shares Outstanding | 65.09 M | ||||
| Shares Owned By Insiders | 19.27 % | ||||
| Shares Owned By Institutions | 3.00 % | ||||
| Number Of Shares Shorted | 89.85 K | ||||
| Price To Earning | 125.00 X | ||||
| Price To Book | 24.11 X | ||||
| Price To Sales | 1.45 X | ||||
| Revenue | 3.57 M | ||||
| Gross Profit | 1.79 M | ||||
| EBITDA | (633 K) | ||||
| Net Income | (1.21 M) | ||||
| Cash And Equivalents | 89 K | ||||
| Total Debt | 105 K | ||||
| Debt To Equity | 2.40 % | ||||
| Current Ratio | 0.86 X | ||||
| Book Value Per Share | 0 X | ||||
| Cash Flow From Operations | (719 K) | ||||
| Short Ratio | 0.73 X | ||||
| Earnings Per Share | (0.03) X | ||||
| Target Price | 6.0 | ||||
| Number Of Employees | 12 | ||||
| Beta | 2.45 | ||||
| Market Capitalization | 3.25 M | ||||
| Total Asset | 1.74 M | ||||
| Retained Earnings | (418.63 M) | ||||
| Working Capital | 10.89 M | ||||
| Current Asset | 14.13 M | ||||
| Current Liabilities | 3.24 M | ||||
| Net Asset | 1.74 M |
About Acura Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Acura Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Acura Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Acura Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Acura Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Acura Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acura Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Acura Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Acura Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Acura Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Acura Pharmaceuticals to buy it.
The correlation of Acura Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Acura Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Acura Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Acura Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in employment. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Consideration for investing in Acura OTC Stock
If you are still planning to invest in Acura Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Acura Pharmaceuticals' history and understand the potential risks before investing.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Stocks Directory Find actively traded stocks across global markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |